Publication:
Novel strategies in nephrology: what to expect from the future?

Simple item page
dc.contributor.coauthorSoler, Maria J.
dc.contributor.coauthorOrtiz, Alberto
dc.contributor.coauthorCovic, Adrian
dc.contributor.kuauthorÇöpür, Sidar
dc.contributor.kuauthorKanbay, Mehmet
dc.contributor.kuauthorTanrıöver, Cem
dc.contributor.kuauthorYavuz, Furkan
dc.contributor.kuprofileResearcher
dc.contributor.kuprofileFaculty Member
dc.contributor.kuprofileUndergraduate Student
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid368625
dc.contributor.yokid110580
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.date.accessioned2024-11-09T12:29:39Z
dc.date.issued2022
dc.description.abstractChronic kidney disease (CKD) will become the fifth global case of death by 2040. Its largest impact is on premature mortality but the number of persons with kidney failure requiring renal replacement therapy (RRT) is also increasing dramatically. Current RRT is suboptimal due to the shortage of kidney donors and dismal outcomes associated with both hemodialysis and peritoneal dialysis. Kidney care needs a revolution. In this review, we provide an update on emerging knowledge and technologies that will allow an earlier diagnosis of CKD, addressing the current so-called blind spot (e.g. imaging and biomarkers), and improve renal replacement therapies (wearable artificial kidneys, xenotransplantation, stem cell-derived therapies, bioengineered and bio-artificial kidneys).
dc.description.fulltextYES
dc.description.indexedbyWoS
dc.description.indexedbyPubMed
dc.description.issue2
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipResearch by A.O. is supported by IS/Fondos FEDER (PI18/01 366, PI19/00 588, PI19/00 815, DTS18/00 032, ERA-PerMed-JTC2018 (KIDNEY ATTACK AC18/00 064) and PERSTIGAN AC18/00 071, ISCIII-RETIC REDinREN RD016/0009), Sociedad Espanola de Nefrologia, FRIAT, Comunidad de Madrid en Biomedicina B2017/BMD-3686 CIFRA2-CM, Instituto de Salud Carlos III (ISCIII) RICORS program to RICORS2040 (RD21/0005/0001) and SPACKDc PMP21/00 109, FEDER funds. RD16/0009.
dc.description.versionPublisher version
dc.description.volume16
dc.formatpdf
dc.identifier.doi10.1093/ckj/sfac212
dc.identifier.eissn2048-8513
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR04078
dc.identifier.issn2048-8505
dc.identifier.linkhttps://doi.org/10.1093/ckj/sfac212
dc.identifier.quartileQ1
dc.identifier.urihttps://hdl.handle.net/20.500.14288/1866
dc.identifier.wos872321500001
dc.keywordsArtificial kidney
dc.keywordsBioengineering
dc.keywordsChronic kidney disease
dc.keywordsInduced Pluripotent stem cells
dc.keywordsXenotransplantation
dc.languageEnglish
dc.publisherOxford University Press (OUP)
dc.relation.grantnoNA
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/10963
dc.sourceClinical Kidney Journal
dc.subjectUrology and nephrology
dc.titleNovel strategies in nephrology: what to expect from the future?
dc.typeReview
dspace.entity.typePublication
local.contributor.authorid0000-0003-0190-2746
local.contributor.authorid0000-0002-1297-0675
local.contributor.authoridN/A
local.contributor.authoridN/A
local.contributor.kuauthorÇöpür, Sidar
local.contributor.kuauthorKanbay, Mehmet
local.contributor.kuauthorTanrıöver, Cem
local.contributor.kuauthorYavuz, Furkan

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
10963.pdf
Size:
1.16 MB
Format:
Adobe Portable Document Format
Download

Collections

Publications with Fulltext